pharmaphorum

FEBRUARY 23, 2022

Takeda has forged another alliance as it continues a push into gene therapy, agreeing a deal worth up to $2 billion with Code Biotherapeutics for opt-in rights to four candidates for rare diseases. The post Takeda grows in gene therapies again with $2bn Code Bio deal appeared first on. Last October it signed a $3.6 billion-plus.

Gene Therapy 104

Gene Therapy Gene Gene Sequencing Immune Response 104

pharmaphorum

MAY 18, 2021

.” The interim phase 2 results show that two doses of the plant-derived jab stimulated neutralising antibody levels that are around 10 times higher than those in a panel of sera from patients recovering from COVID-19, with a similar response seen in adults and the elderly.

Immune Response 64

Immune Response Vaccination Vaccine Gene Sequencing 64

Drug Discovery World

FEBRUARY 5, 2024

Through early diagnosis and precision medicine, we can improve quality of life and enable more people with cancer to survive. To promote the immune response, the posology of biologics is usually high and requires intravenous injection, which raises safety concerns and significantly reduces patient compliance.

Research 116

Research Drug Delivery Systems Gene Sequencing Trials 116